AlzBiomarker
Dementia with Lewy Bodies vs Alzheimer's Disease: hFABP (Plasma and Serum)
Meta-analysis of two studies showed that levels of hFABP in the sera of people with dementia with Lewy bodies are more than double those of people with Alzheimer's disease (effect size = 2.276, p = 0.001). For comparison levels of hFABP in blood were found to be similar in individuals with Alzheimer's disease and control subjects.
Loading data...